Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 101 The United Laboratories International Holdings Limited Annual Report 2025 14. FIVE HIGHEST PAID EMPLOYEES For the years ended 31 December 2025 and 2024, all the five highest paid individuals of the Group are directors of the Company, details of which are included in Note 13. 15. DIVIDENDS 2025 2024 RMB’000 RMB’000 Dividends for ordinary shareholders of the Company recognised as distribution during the current year – 2025 interim dividend RMB16 cents (2024: 2024 interim dividend RMB16 cents) per share 315,684 290,724 – 2024 final dividend RMB28 cents (2024: 2023 final dividend RMB28 cents) per share 508,768 508,768 – 2024 special dividend RMB12 cents (2024: 2023 special dividend RMB12 cents) per share 218,044 218,043 1,042,496 1,017,535 Subsequent to the end of the reporting period, a final dividend of RMB26 cents (2024: RMB28 cents) per ordinary share in respect of the year ended 31 December 2025, in an aggregate amount of RMB512,987,000 (2024: RMB726,773,000), have been proposed by the directors of the Company and are subject to approval by the shareholders in the forthcoming annual general meeting.